Expression of oestrogen receptor Β and prognosis of colorectal cancer

British Journal of Cancer

Volumn 107, Issue 5, 2012, Pages 831-839

  Rudolph, A ^a   Toth, C ^a,b   Hoffmeister, M ^a   Roth, W ^a,b   Herpel, E ^a,b   Jansen, L ^a   Marx, A ^c   Brenner, H ^a   Chang Claude, J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

colorectal cancer; nuclear receptor; oestrogen receptor ; prognosis; prospective cohort; sex steroids

Indexed keywords

ESTROGEN RECEPTOR BETA;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SURVIVAL ANALYSIS;

EID: 84865436063     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.323     Document Type: Article

References (39)

1. Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, Papagni S, Guido R, Maiorano E, Ingravallo G, Comelli MC, Francavilla A, Di Leo A (2010) Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/\+ mice. Carcinogenesis 31(2): 269-274
2. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M (2011) Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154(1): 22-30
3. Campbell-Thompson M, Lynch IJ, Bhardwaj B (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 61(2): 632-640 (Pubitemid 32128626)
4. Carder PJ, Murphy CE, Dervan P, Kennedy M, McCann A, Saunders PT, Shaaban AM, Foster CS, Witton CJ, Bartlett JM, Walker RA, Speirs V (2005) A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue. Breast Cancer Res Treat 92(3): 287-293 (Pubitemid 41279638)
5. Chambless LE, Cummiskey CP, Cui G (2011) Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med 30(1): 22-38
6. Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. J Am Med Ass 302(6): 649-658
7. Cuzick J, DeCensi A, Arun B, Brown PH, Castiglione M, Dunn B, Forbes JF, Glaus A, Howell A, von Minckwitz G, Vogel V, Zwierzina H (2011) Preventive therapy for breast cancer: a consensus statement. Lancet Oncol 12(5): 496-503
8. Dahabreh IJ, Terasawa T, Castaldi PJ, Trikalinos TA (2011) Systematic review: anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer. Ann Intern Med 154(1): 37-49
9. Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793): 771-784
10. Elbanna HG, Ebrahim MA, Abbas AM, Zalata K, Hashim MA (2012) Potential value of estrogen receptor Beta expression in colorectal carcinoma: interaction with apoptotic index. J Gastrointest Cancer 43(1): 56-62
11. Fang YJ, Lu ZH, Wang F, Wu XJ, Li LR, Zhang LY, Pan ZZ, Wan DS (2010) Prognostic impact of ERbeta and MMP7 expression on overall survival in colon cancer. Tumour Biol 31(6): 651-658
12. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12): 2893-2917
13. Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80(1): 27-38
14. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW (2000) Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 60(2): 245-248 (Pubitemid 30070743)
15. Giltnane JM, Rimm DL (2004) Technology insight: Identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 1(2): 104-111 (Pubitemid 40823750)
16. Gönen M, Heller G (2005) Concordance probability and discriminatory power in proportional hazards regression. Biometrika 92(4): 965-970 (Pubitemid 41681247)
17. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, Strom A, Gustafsson JA (2009) Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res 69(15): 6100-6106
18. Hartman J, Gustafsson JA (2010) Estrogen receptors in colorectal cancer: goalkeepers, strikers, or bystanders? Cancer Prev Res 3(8): 897-899
19. Heinze G, Schemper M (2001) A Solution to the problem of monotone likelihood in cox regression. Biometrics 57(1): 114-119 (Pubitemid 32200144)
20. Hoffmeister M, Raum E, Krtschil A, Chang-Claude J, Brenner H (2009) No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clin Pharmacol Ther 86(4): 416-424
21. Jassam N, Bell SM, Speirs V, Quirke P (2005) Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 14(1): 17-21
22. Jourdan F, Sebbagh N, Comperat E, Mourra N, Flahault A, Olschwang S, Duval A, Hamelin R, Flejou JF (2003) Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443(2): 115-121 (Pubitemid 37056134)
23. Kennelly R, Kavanagh DO, Hogan AM, Winter DC (2008) Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 9(4): 385-391 (Pubitemid 351411655)
24. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andrico-poulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG (2003) Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39(9): 1251-1258 (Pubitemid 36579196)
25. Leung YK, Mak P, Hassan S, Ho SM (2006) Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc Natl Acad Sci USA 103(35): 13162-13167 (Pubitemid 44338933)
26. Lilla C, Verla-Tebit E, Risch A, Jager B, Hoffmeister M, Brenner H, Chang-Claude J (2006) Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15(1): 99-107
27. Lin KJ, Cheung WY, Lai JY, Giovannucci EL (2012) The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer 130(2): 419-430
28. Martineti V, Picariello L, Tognarini I, Carbonell SS, Gozzini A, Azzari C, Mavilia C, Tanini A, Falchetti A, Fiorelli G, Tonelli F, Brandi ML (2005) ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer 12(2): 455-469 (Pubitemid 40896459)
29. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS (2006) Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24(22): 3527-3534 (Pubitemid 46630522)
30. Nagelkerke NJD (1991) A note on a general definition of the coefficient of determination. Biometrika 78(3): 691-692
31. Papaxoinis K, Triantafyllou K, Sasco AJ, Nicolopoulou-Stamati P, Ladas SD (2010) Subsite-specific differences of estrogen receptor beta expression in the normal colonic epithelium: implications for carcinogenesis and colorectal cancer epidemiology. Eur J Gastroenterol Hepatol 22(5): 614-619
32. Peng B, Lu B, Leygue E, Murphy LC (2003) Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30(1): 13-29 (Pubitemid 36305253)
33. Saleiro D, Murillo G, Lubahn DB, Kopelovich L, Korach KS, Mehta RG (2010) Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice. Cancer Prev Res 3(9): 1198-1204
34. Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4): 343-346 (Pubitemid 26342716)
35. Skliris GP, Parkes AT, Limer JL, Burdall SE, Carder PJ, Speirs V (2002) Evaluation of seven oestrogen receptor beta antibodies for immunohis- tochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol 197(2): 155-162 (Pubitemid 34567602)
36. Speirs V, Green CA, Shaaban AM (2008) Oestrogen receptor beta immunohistochemistry: time to get it right? J Clin Pathol 61(10): 1150-1151
37. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M, Gustafsson JA (2006) Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci USA 103(8): 2959-2964
38. Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT (2005) ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 207(1): 53-60 (Pubitemid 41200714)
39. Zhang X, Loberiza FR, Klein JP, Zhang MJ (2007) A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed 88(2): 95-101 (Pubitemid 47588441)